Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 Evaluation of NeuCaVis PET Imaging in Healthy Volunteers
NCT07253753Phase 1Completed
- Sponsor
- Yellowbird Diagnostics
- Start
- Apr 2026
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of NeuCaVis, sponsored by Yellowbird Diagnostics. Primary endpoint: Incidence of treatment emergent adverse events and treatment emergent serious adverse events. Started Apr 2026; status: completed.
02
Drugs
NeuCaVis
Beyond the preview
Go deeper on NCT07253753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07253753.